Reasons to
subscribe
on Hubb
Unified Worldwide Network
in Your Language
Unlimited Ads for FREE
First Page on Search Engines
under HUBB for FREE
Choose Your Own Keywords
for FREE
Multiple Service Apps for FREE
No Commission or Hidden Fees
Direct Contact with Customers
without Agents
Ability to Have Your Own Website
under HUBB for FREE
Expand Your Business
Overseas for FREE
Register now

Ascentage Pharma

Promote 44 views
Service category: Healthcare
Payment:

Description

Ascentage Pharma (6855.HK) is a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. The company focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limited.

Ascentage Pharma has built a pipeline of eight clinical drug candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. The company is conducting more than 30 Phase I/II clinical trials to evaluate the eight drug candidates in the US, Australia, and China.

Promotions and offers

icon-applicant-user
Contact person: Ascentage Pharma
+8651285557777 BD@ascentagepharma.com
TOP
All the services you need on one platform
Ordering Services Online
All the services you need on one platform
Ordering Services Online

New Services

Coming soon

Show all
Close
Login on Hubb
Reset password